David Weiner
-
Wistar Institute Recruits HIV Vaccine Pioneer Torben Schiffner, Ph.D., to Advance Next-Generation Immune Therapies
The Wistar Institute, an international biomedical research leader in cancer, immunology, and infectious disease, has announced the recruitment of Torben Schiffner, Ph.D., to its Vaccine &…
-
Wistar Scientists Develop Two-Vaccine Strategy to Fight T Cell Lymphoma
T cell lymphomas are notoriously difficult to treat because immunotherapy, despite being one of the most effective therapies for treating cancer, can’t easily distinguish cancerous…
-
Wistar Institute Recruits Vincent Wu to Join Vaccine & Immunotherapy Center as Caspar Wistar Fellow
The Wistar Institute, an international biomedical research leader in cancer, immunology, and infectious disease, is pleased to announce the recruitment of Vincent Wu, Ph.D., to Wistar’s Vaccine…
-
First-in-Human Study of DNA Antibody Replicas Generate Efficient and Long-Lasting Biologic Production of Human Antiviral Antibodies
A multidisciplinary team of scientists led by The Wistar Institute, including Perelman School of Medicine at the University of Pennsylvania, AstraZeneca and Inovio Pharmaceuticals, published in Nature Medicine a breakthrough…
Founding Partners
Advertisement
Affiliate Partners
